| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/21/2007 | CN1915405A Medication of medical broth for treating disease of night sweat in type of damp heat, and preparation method |
| 02/21/2007 | CN1915403A Medication of medical broth for treating disease of wean summer fever in type of deficiency of the lung and kidney, and preparation method |
| 02/21/2007 | CN1915394A Medicinal food for treating disease of night sweat, and preparation method |
| 02/21/2007 | CN1915393A Medication of medical broth for treating disease of night sweat in type of deficiency of stomach yin, and preparation method |
| 02/21/2007 | CN1915390A Medication of pasting on umbilicus to treat disease of night sweat, and preparation method |
| 02/21/2007 | CN1915388A Medicinal food for treating disease of night sweat in type of yin deficiency, and preparation method |
| 02/21/2007 | CN1915387A Medicinal food for treating disease of night sweat in type of the sinking of qi, and preparation method |
| 02/21/2007 | CN1915383A Medication of medical broth for treating disease of wean hotness in type of damaged lung and stomach, and preparation method |
| 02/21/2007 | CN1915378A Medication of foot-bath for treating disease of spontaneous perspiration, and preparation method |
| 02/21/2007 | CN1915377A Medication of medical broth for treating disease of spontaneous perspiration, and preparation method |
| 02/21/2007 | CN1915368A Medication of medical broth for treating disease of spontaneous perspiration in type of severity, and preparation method |
| 02/21/2007 | CN1915366A Medication of medical broth for treating disease of perspiration in the palms and soles in type of impairment of yin from heat fire of the vital gate, and preparation method |
| 02/21/2007 | CN1915364A Medicinal food for treating disease of night sweat in type of qi deficiency in heart and lung, and preparation method |
| 02/21/2007 | CN1915360A Medication of embrocation for treating disease of night sweat due to deficiency of yin, and preparation method |
| 02/21/2007 | CN1915349A Medication of medical broth for treating disease of sweating in the armpit in type of deficiency of essence and blood, and preparation method |
| 02/21/2007 | CN1915341A Medication of medical broth for treating disease of sweating in the armpit in liver yang damp-heat type, and preparation method |
| 02/21/2007 | CN1915339A Medication of medical broth for treating disease of yin perspiration in insufficiency of the kidney-yang type, and preparation method |
| 02/21/2007 | CN1915330A Medicinal food for treating disease of night sweat in deficiency of qi type, and preparation method |
| 02/21/2007 | CN1915327A Medication for pasting on umbilicus to treat disease of night sweat due to yin deficiency, and preparation method |
| 02/21/2007 | CN1915322A Medication of medical broth for treating disease of perspiration of forehead, and preparation method |
| 02/21/2007 | CN1915321A Medication of medical broth for treating asthenia of the spleen and stomach type perspiration disease in the palms and soles, and preparation method |
| 02/21/2007 | CN1915313A Medicinal food for treating night sweat disease in deficency of the splinic qi type, and preparation method |
| 02/21/2007 | CN1915309A Medication of medical broth for treating perspiration on forehead in insufficiency of yang-qi type, and preparation method |
| 02/21/2007 | CN1915288A Medication for pasting on umbilicus to treat spontaneous sweating disease in dryness-heat scorching the lung type |
| 02/21/2007 | CN1915230A Injection in large capacity of sodium sulfonate containing tanshinone óÄA and preparation method |
| 02/21/2007 | CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 02/21/2007 | CN1301249C Clausend wanpi acidamine C5 hydroxy derivative and N substituted derivative, its preparation method and its medicinal composition and use |
| 02/21/2007 | CN1301134C Novel immune effect compound |
| 02/21/2007 | CN1301117C Ginseng and aconite granules for treating qi vacuity and yang desertion and its preparation method |
| 02/21/2007 | CN1301113C Method for making preparation of rhodiola root |
| 02/21/2007 | CN1301111C Use of phenoxthine compounds in preparing medicnies for promoting radio-sensitive medicines |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179921 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 02/20/2007 | US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179818 Substituted aminoquinuclidine compounds |
| 02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
| 02/20/2007 | US7179811 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections |
| 02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/20/2007 | US7179803 Method of modulating ion channel functional activity |
| 02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | US7179792 Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least one other active ingredient and the use of the product |
| 02/20/2007 | US7179788 Synergistic mixtur eof glucangon-like peptide , in solid phase, and insulin solution, in liquid phase; antidiabetic agents; obesity |
| 02/20/2007 | US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use |
| 02/20/2007 | US7179627 Cyclooxygenase variants and methods of use |
| 02/20/2007 | US7179461 Topical applying kinase to eye surface |
| 02/20/2007 | US7179457 Modified to include heterologous insertion downstream of its replicase open reading frames; insertion preferably comprises one or more protein-coding regions ideal for virus-like particles packaging |
| 02/20/2007 | CA2455050C Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 02/20/2007 | CA2422374C Purine derivatives |
| 02/20/2007 | CA2371174C Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 02/20/2007 | CA2344574C Thyroid receptor ligands |
| 02/20/2007 | CA2289979C Methods of modulating immune coagulation |
| 02/20/2007 | CA2263561C Thienopyrimidines |
| 02/20/2007 | CA2223908C Use of squalamine for the manufacture of a medicament for inhibiting nhe |
| 02/20/2007 | CA2198389C Triphenylethylenes for the prevention and treatment of osteoporosis |
| 02/20/2007 | CA2128044C Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor |
| 02/20/2007 | CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor |
| 02/15/2007 | WO2007018319A1 Pyridylphenol compound and use thereof |
| 02/15/2007 | WO2007018318A1 Method for gene expression specific to cerebellar astrocyte and/or basket cell |
| 02/15/2007 | WO2007018281A1 Akt ACTIVATION INHIBITOR |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007018168A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | WO2007018137A1 Multikinase inhibitor |
| 02/15/2007 | WO2007018124A1 Agent for enhancing collagen production and utilization of the same |
| 02/15/2007 | WO2007018095A1 Method of producing extract derived from hypsizigus marmoreus |
| 02/15/2007 | WO2006136829A3 Pyrazole derivatives and their use as pka and pkb modulators |
| 02/15/2007 | WO2006009975A3 Histamine to treat disorders affecting muscle function |
| 02/15/2007 | US20070039064 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
| 02/15/2007 | US20070039063 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy |
| 02/15/2007 | US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 02/15/2007 | US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof |
| 02/15/2007 | US20070037884 Novel succinate salt of O-desmethyl-venlafaxine |
| 02/15/2007 | US20070037879 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037878 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037870 Novel substance having alpha-glucosidase inhibiting activity and food containing the same |
| 02/15/2007 | US20070037856 Pyrrole-Type compounds, compositions and methods for treating cancer or viral disease |
| 02/15/2007 | US20070037851 Inhibits binding of CCR3 ligands such as eotaxins to their target cells; inhibits physiological effects of binding; therapeutic and prophylactic agents for asthma, rhinitis, dermatitis, urticaria, conjunctivitis, inflammatory bowel; tissue infiltration of eosinophils, basophils, activated T cells |
| 02/15/2007 | US20070037850 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 02/15/2007 | US20070037843 Zolpidem hemitartrate |
| 02/15/2007 | US20070037841 Inhibitors |
| 02/15/2007 | US20070037836 Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide |
| 02/15/2007 | US20070037834 Bicyclic pyrimidine derivatives |
| 02/15/2007 | US20070037832 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis |
| 02/15/2007 | US20070037825 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 02/15/2007 | US20070037803 Benzimidazole derivatives |
| 02/15/2007 | US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037778 Therapy and prophylaxis of Alzheimer's Disease and Down's syndrome; inhibiting beta amyloid production; 2,4-difluoro-N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]benzenesulfonamide |
| 02/15/2007 | US20070037773 Methods and compositions for treating flaviviruses and pestiviruses |
| 02/15/2007 | US20070037770 Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use |
| 02/15/2007 | US20070037765 gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 02/15/2007 | US20070037735 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/15/2007 | US20070037606 Transmitter of wireless microphone, receiver for wireless microphone, portable information communication device, and wireless microphone communication system |
| 02/15/2007 | US20070037269 Mutants of desoxycytidine kinase having extended enzymatic activity |
| 02/15/2007 | US20070036872 Alpha-glucosidase activity inhibitor |